Factors associated with nonadherence to medication in kidney transplant recipients

Nephron - Clinical Practice

Volumn 117, Issue 1, 2010, Pages

  Goldfarb Rumyantzev, Alexander S ^a,c   Wright, Seth ^a   Ragasa, Regina ^a   Ostler, Doug ^b   Van Orden, Jennifer ^b   Smith, Lonnie ^b   Efimova, Ekaterina ^b   Emerson, Lyska ^b   Sandhu, Gurprataap Singh ^a   Shihab, Fuad ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Adherence; Compliance; Complications; Immunosuppression; Kidney transplantation; Outcome

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; CORRELATION ANALYSIS; DIALYSIS; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SMOKING;

ADULT; CHI-SQUARE DISTRIBUTION; COMORBIDITY; EMPLOYMENT; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIVING DONORS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS;

EID: 77955107857     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319645     Document Type: Article

References (35)

1. Butler JA, Roderick P, Mullee M, Mason JC, et al: Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77: 769-776.
2. Vlaminck H, Maes B, Evers G, Verbeke G, et al: Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004; 4: 1509-1513.
3. Chisholm MA, Kwong WJ, Spivey CA: Associations of characteristics of renal transplant recipients with clinicians' perceptions of adherence to immunosuppressant therapy. Transplantation 2007; 84: 1145-1150.
4. Dew MA, DiMartini AF, De Vito Dabbs A, Myaskovsky L, et al: Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007; 83: 858-873.
5. Morrissey PE, Flynn ML, Lin S: Medication noncompliance and its implications in transplant recipients. Drugs 2007; 67: 1463-1481.
6. Denhaerynck K, Desmyttere A, Dobbels F, Moons P, et al: Nonadherence with immunosuppressive drugs: US compared with European kidney transplant recipients. Prog Transplant 2006; 16: 206-214.
7. Denhaerynck K, Dobbels F, Cleemput I, Desmyttere A, et al: Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int 2005; 18: 1121-1133.
8. De Geest S, Borgermans L, Gemoets H, Abraham I, et al: Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59: 340-347.
9. Farmer KC: Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 1999; 21: 1074-1090; discussion 1073.
10. Hathaway DK, Combs C, De Geest S, Stergachis A, et al: Patient compliance in transplantation: a report on the perceptions of transplant clinicians. Transplant Proc 1999; 31: 10S-13S.
11. Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24: 67-74.
12. Abbott K: Medication compliance in transplantation. Am J Transplant 2007; 7: 2647-2649.
13. Butler JA, Peveler RC, Roderick P, Horne R, et al: Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004; 77: 786-789.
14. Schafer-Keller P, Steiger J, Bock A, Denhaerynck K, et al: Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 2008; 8: 616-626.
15. Weng FL, Israni AK, Joffe MM, Hoy T, et al: Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol 2005; 16: 1839-1848.
16. Byerly M, Fisher R, Whatley K, Holland R, et al: A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 2005; 133: 129-133.
17. Garber MC, Nau DP, Erickson SR, Aikens JE, et al: The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004; 42: 649-652.
18. Horne R, Weinman J: Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555-567.
19. Davies SJ, Russell L, Bryan J, Phillips L, et al: Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 1995; 26: 353-361.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
21. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, et al: Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant 2005; 20: 167-175.
22. Tang H, Chelamcharla M, Baird BC, Shihab FS, et al: Factors affecting kidney-transplant outcome in recipients with lupus nephritis. Clin Transplant 2008; 22: 263-272.
23. Bartosh SM, Ryckman FC, Shaddy R, Michaels MG, et al: A national conference to determine research priorities in pediatric solid organ transplantation. Pediatr Transplant 2008; 12: 153-166.
24. Rianthavorn P, Ettenger RB: Medication non-adherence in the adolescent renal transplant recipient: a clinician's viewpoint. Pediatr Transplant 2005; 9: 398-407.
25. Basra RK, Wagg A, Chapple C, Cardozo L, et al: A review of adherence to drug therapy in patients with overactive bladder. BJU Int 2008; 102: 774-779.
26. Shah NR, Hirsch AG, Zacker C, Wood GC, et al: Predictors of first-fill adherence for patients with hypertension. Am J Hypertens 2009; 24: 233-237.
27. Ediger JP, Walker JR, Graff L, Lix L, et al: Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007; 102: 1417-1426.
28. Gordon EJ, Prohaska TR, Gallant MP, Siminoff LA: Adherence to immunosuppression: a prospective diary study. Transplant Proc 2007; 39: 3081-3085.
29. Takemoto SK, Pinsky BW, Schnitzler MA, Lentine KL, et al: A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients. Am J Transplant 2007; 7: 2704-2711.
30. Butler JA, Peveler RC, Roderick P, Smith PW, et al: Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross-sectional study. Nephrol Dial Transplant 2004; 19: 3144-3149.
31. Yavuz A, Tuncer M, Erdogan O, Gurkan A, et al: Is there any effect of compliance on clinical parameters of renal transplant recipients? Transplant Proc 2004; 36: 120-121.
32. Feinstein S, Keich R, Becker-Cohen R, Rinat C, et al: Is noncompliance among adolescent renal transplant recipients inevitable? Pediatrics 2005; 115: 969-973.
33. Denhaerynck K, Steiger J, Bock A, Schafer- Keller P, et al: Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 2007; 7: 108-116.
34. Ghods AJ, Nasrollahzadeh D, Argani H: Risk factors for noncompliance to immunosuppressive medications in renal transplant recipients. Transplant Proc 2003; 35: 2609-2611.
35. Greenstein S, Siegal B: Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 1998; 66: 1718-1726.